Rocket Lab keeps executing, guiding Q3 revenue to $250-265M, up 61-70% year over year and above the roughly $236M analyst estimate. Q2 results were mostly in line with expectations, with revenue up 62% year over year. x.comÂ
Hamid
Founder & CEO of Savvy Trader/Earnings Hub, Co-Host of BuyHoldRant
Rocket Lab's growing Space Systems business positions it to provide more than launches for the space economy. It generated $189.5M in Q2, 81% of revenue; if its pending Iridium acquisition closes, it would gain a global satellite communications network. At about $51, this is one of the most compelling long-term opportunities in the space sector over 3-5 years, provided it keeps executing. Neutron's launch has slipped to 2027, and execution risks remain. x.com x.com x.comÂ
Rocket Lab's latest quarter supports a move toward $122, with growth, backlog and guidance all stepping up. Revenue cleared about $200M, up roughly 60% year over year, and backlog now exceeds $2B. Liquidity is strong, with about $1.5B in cash and more than $2B in total liquidity. Management again guided Q2 higher, to $232M versus a $208M street consensus. x.comÂ
Rocket Lab shares look set to grind as Neutron's first flight slips, even though the core business is at its strongest. Q2 revenue hit a record $234.1M, up 62%, and backlog rose 137% to $2.356B. But the Q3 guide cuts GAAP gross margin to 29-31% from 36.1%, below the ~37.6% expected, with adjusted EBITDA losses widening to $17-23M on low-margin satellite programs, Mynaric integration and Neutron spending. A Q1 2027 Neutron debut is now the base case, which will disappoint high expectations. x.comÂ
Rocket Lab's growth outlook looks great after a record quarter and a guidance beat. Revenue of $234M topped the $232M estimate, and backlog reached $2.36B, up 137% year on year and above the $2.29B estimate. Q3 revenue guidance of $258M is well above the $238M estimate. It also introduced GHOST, a containerized launch site deployable worldwide for Electron and HASTE, with two Alaska pads planned for 2027. The stock could still retest the $70-73 area. x.comÂ
Rocket Lab's trajectory is good, but it remains a pre-profit growth story, graded C. Q2 revenue rose 62% to $234.1 million, with product revenue nearly doubling as Neutron and space-systems work ramps. The net loss narrowed from $66.4 million to $49.3 million, helped by more interest income and less interest expense, while the operating loss barely moved at $57.5 million. x.comÂ
Rocket Lab still looks ridiculously expensive at 29 times forward sales against SpaceX at 22 times, even after a 65% fall. At 22 times, Rocket Lab would be roughly $38, and SpaceX would still be the pick. SpaceX also has better forward guidance; Rocket Lab's negative adjusted EBITDA makes sales multiples the valuation yardstick. x.com x.com x.com x.comÂ
Good SpaceX earnings could help Rocket Lab lead the new-space sector higher with a rally as violent as its capitulation. Rocket Lab is the sector leader outside SpaceX; its RSI is extremely oversold, the lower Bollinger band is overstretched and MACD's negative divergence is subsiding. Three upside gaps lie at $55.25-59.18, $64.22-65.71 and $73.11-74.76. The highest should fill before year-end, though the exact date is hard to predict. x.com x.comÂ
Rocket Lab's expanding contracted work improves medium- and long-term revenue visibility. Synspective added 20 dedicated Electron launches for 2028-31, bringing its total to 47; backlog reached $2.4 billion after more than $1 billion in Q2 and early-Q3 awards. Space Systems broadens the business beyond launches, while Neutron's medium-lift upside still depends on reaching operational orbit. x.comÂ
Rocket Lab could face a difficult 9-12 months because much of the space industry's future is already priced into equity valuations, even as its business and backlog grow. A monthly close below the $61 21-month EMA would raise the risk that the uptrend has ended and shift attention toward $35-45 for a better long-term entry; holding $61 preserves a more constructive reading. The company could still trade considerably higher over a longer horizon. x.comÂ
Rocket Lab's record Q2 and Iridium deal show it becoming an end-to-end space and defense platform that can capture more value than a launch-only company. Q2 revenue hit a record $234M, up 62%, and backlog a record $2.36B after over $1B of new contracts. Iridium adds over $870M of annual L-band revenue tied to government and enterprise. Launch revenue fell 30% sequentially largely because more HASTE defense work is recognized over time; Mynaric integration weighs on near-term margins. x.comÂ